Cowen and Company’s Alpha Healthcare Acquisition Corp III Units ALPAU Stock Holding History

Cowen and Company’s Portfolio ALPAU Stock Details ALPAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-700,000	Closed	-$7.16M	–	679
2023 Q1	$7.16M	Hold	700,000	–	–	0.84%	28
2022 Q4	$6.99M	Hold	700,000	–	–	0.73%	26
2022 Q3	$6.85M	Hold	700,000	–	–	0.65%	35
2022 Q2	$6.83M	Hold	700,000	–	–	0.66%	35
2022 Q1	$6.89M	Hold	700,000	–	–	0.66%	34
2021 Q4	$6.85M	Hold	700,000	–	–	0.62%	31
2021 Q3	$6.95M	Buy	+700,000	New	+$6.96M	0.33%	36

Other funds holding ALPAU

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

LIM

Longfellow Investment Management Boston, Massachusetts $480M AUM 8% 1-Year Est. Return

Cowen and Company's ALPAU Position: Q2 2023 in Review

Cowen and Company sold out of Alpha Healthcare Acquisition Corp III Units (ALPAU) in Q2 2023, closing a stake of 700,000 shares — an estimated $7.16M sold.

Cowen and Company first reported a position in ALPAU in Q3 2021 and held it in 7 quarters. The position peaked at $7.16M in Q1 2023. 4 funds tracked by Wall St. Rank hold ALPAU as of Q2 2023.

Cowen and Company reported no remaining Alpha Healthcare Acquisition Corp III Units position as of Q2 2023 after selling out during the quarter.
Cowen and Company sold 700,000 Alpha Healthcare Acquisition Corp III Units shares in Q2 2023, an estimated $7.16M.
Cowen and Company first reported a position in Alpha Healthcare Acquisition Corp III Units in Q3 2021 and held it in 7 quarters.
Cowen and Company's Alpha Healthcare Acquisition Corp III Units position peaked at $7.16M in Q1 2023.
4 funds tracked by Wall St. Rank held Alpha Healthcare Acquisition Corp III Units as of Q2 2023.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.